Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients

BACKGROUND: Anti-TNF treatment may be useful for the treatment of patients with refractory juvenile dermatomyositis (JDM). The aim of this study was to describe the use of infliximab and adalimumab therapy in juvenile dermatomyositis as an adjunctive treatment. METHODS: Sixty children recruited to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Campanilho-Marques, Raquel, Deakin, Claire T., Simou, Stefania, Papadopoulou, Charalampia, Wedderburn, Lucy R., Pilkington, Clarissa A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161150/
https://www.ncbi.nlm.nih.gov/pubmed/32293539
http://dx.doi.org/10.1186/s13075-020-02164-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161150/
https://www.ncbi.nlm.nih.gov/pubmed/32293539
http://dx.doi.org/10.1186/s13075-020-02164-5

Ejemplares similares